| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 44 |
| 1 | PREDNISONE | 41 |
| 2 | LOPERAMIDE HYDROCHLORIDE | 38 |
| 3 | LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE | 38 |
| 4 | TOCILIZUMAB | 38 |
| 5 | CLONAZEPAM | 37 |
| 6 | ABATACEPT | 35 |
| 7 | DILTIAZEM HYDROCHLORIDE | 35 |
| 8 | IRBESARTAN | 35 |
| 9 | LEFLUNOMIDE | 35 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BISMUTH SUBGALLATE | 1 | 0.0217 |
| 1 | BUTALBITAL AND ACETAMINOPHEN | 1 | 0.0016 |
| 2 | CALCIUM GLUCONATE | 17 | 0.0014 |
| 3 | DILTIAZEM HYDROCHLORIDE | 35 | 0.0012 |
| 4 | ADALIMUMAB-RYVK | 1 | 0.0009 |
| 5 | AVUTOMETINIB POTASSIUM AND DEFACTINIB HYDROCHLORIDE | 1 | 0.0009 |
| 6 | LOPERAMIDE HYDROCHLORIDE | 38 | 0.0008 |
| 7 | PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION | 1 | 0.0008 |
| 8 | IRBESARTAN | 35 | 0.0008 |
| 9 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | 1 | 0.0008 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 58 |
| 1 | Benzodiazepine [EPC] | 48 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 41 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 38 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 36 |
| 5 | Antirheumatic Agent [EPC] | 35 |
| 6 | Selective T Cell Costimulation Modulator [EPC] | 35 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 29 |
| 8 | Integrin Receptor Antagonist [EPC] | 25 |
| 9 | Calcium [EPC] | 18 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 15 | 0.0005 |
| 1 | mu-Opioid Receptor Agonist [EPC] | 1 | 0.0003 |
| 2 | Antirheumatic Agent [EPC] | 35 | 0.0003 |
| 3 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 4 | Integrin Receptor Antagonist [EPC] | 25 | 0.0003 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 38 | 0.0003 |
| 6 | Antisense Oligonucleotide [EPC] | 3 | 0.0003 |
| 7 | Selective T Cell Costimulation Modulator [EPC] | 35 | 0.0003 |
| 8 | Serotonin Reuptake Inhibitor [EPC] | 18 | 0.0002 |
| 9 | Influenza A M2 Protein Inhibitor [EPC] | 3 | 0.0002 |